Name
Sobrepin 40 mg/5 ml syrup
sobrerolo
What is it and what is it for?
The active ingredient in Sobrepin is sobrerol, a mucolytic. This medicine is used to thin bronchial secretions in the treatment of respiratory conditions characterized by thick, viscous hypersecretion.
The duration of treatment should not exceed 3 days.
What you need to know before taking the medicine
Do not take Sobrepin
- if you are allergic to sobrerol or any of the other ingredients of this medicine (listed in section 6);
- if you are pregnant or breastfeeding. (see “Pregnancy and breastfeeding”).
- in children under 30 months of age
- in children with a history of epilepsy or febrile seizures.
Warnings and precautions
Talk to your doctor or pharmacist before taking Sobrepin.
Pay particular attention:
This medicine contains sobrerol which, in excessive doses, can induce neurological disorders such as convulsions in infants and children.
Do not prolong treatment for more than 3 days due to the risks associated with the accumulation of terpene derivatives in the body, including the brain, and in particular the risk of neuropsychological disorders.
Do not administer doses higher than those recommended to avoid a greater risk of adverse drug reactions and disorders associated with overdose.
The product is flammable, do not bring it near flames.
Children
Do not use Sobrepin in children under 30 months of age, as mucolytics can cause bronchial occlusion (the ability to eliminate bronchial mucus in children under 30 months is limited due to the characteristics of their airways).
Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Side effects with unknown frequency (frequency cannot be estimated from the available data):
- allergic (hypersensitivity) reactions manifested by itching, skin rash, urticaria, edema and dyspnea;
- bronchial obstruction (temporary narrowing of the upper airways);
- gastric (stomach) disorders;
- nausea.
Following the instructions in the package leaflet reduces the risk of side effects.
Reporting of side effects
If you experience any side effects, including any not listed in this leaflet, talk to your doctor or pharmacist. You can also report side effects directly via the national reporting system at: https://www.aifa.gov.it/content/segnalazionireazioni-avverse .
By reporting side effects you can help provide more information on the safety of this medicine.